BioRestorative Therapies, Inc. (BRTX)
Last updated: 2026-10-24 19:25:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
BioRestorative Therapies, Inc. (BRTX) operates in the SERVICES-MISC HEALTH & ALLIED SERVICES, NEC sector and is listed on NASDAQ. The stock is currently priced at $1.65, with a market capitalization of $2.07M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.28 to $34.00. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$2.07M | |
$1.65 | |
$178.00 | |
$1.28 | |
$1.50 | |
813.00 | |
27.54K | |
-- | |
$34.00 | |
$1.28 | |
-- | |
-- |
BioRestorative Therapies, Inc. (BRTX) Latest Closing Stock Price
BioRestorative Therapies, Inc. (BRTX) last closed at $1.50 as of 2026-10-23 23:35:00, unchanged from the previous close of $1.50.
During the latest regular trading session, BRTX traded between $1.28 and $178.00, with a volume of 813.00 shares. The closing price was near the lower end and near the lower end of its 52-week range.
BioRestorative Therapies, Inc. (BRTX) 7-Day Stock Price Change
Over the past seven days, BioRestorative Therapies, Inc. (BRTX) moved from $1.46 to $1.65, representing a gain of 12.67% ($0.19).
The stock traded between $1.28 and $1.67 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 19.57 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
BRTX 52-Week Price Position
Position in Range: 1.1%
BRTX is currently trading at $1.65, placing it 1.1% of the way from its 52-week low of $1.28 to its 52-week high of $34.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is BioRestorative Therapies, Inc. (BRTX)?
BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.
BioRestorative Therapies, Inc. Information
| Industry | SERVICES-MISC HEALTH & ALLIED SERVICES, NEC |
| Employees | 14 |
| Exchange | NASDAQ |
| Company Website |
How to Buy BioRestorative Therapies, Inc. (BRTX) Stock on MEXC
Eligible investors can buy real shares of BioRestorative Therapies, Inc. (BRTX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is BioRestorative Therapies, Inc. (BRTX) stock price today?
2.Is BRTX stock going up or down today?
3.What is BRTX pre-market price?
4.What is BRTX after-hours price?
5.Is BRTX stock trading now?
6.Where does BRTX sit relative to its 52-week high and low?
7.What sector is BioRestorative Therapies, Inc. in?
8.What is BioRestorative Therapies, Inc.'s market capitalization and where is it listed?
9.How is BRTX valued in terms of P/E ratio and EPS?
10.Does BioRestorative Therapies, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
BRTX Stock Calculator
Estimate the value between BRTX shares and USD.
BRTX Shares to USD
1.00 BRTX shares = 1.645 USD
Calculations are estimates based on the latest available price and are for reference only.


